ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Condition : By Disease Heading : Immune System Diseases : ALL_STUDIES


Include trials that are no longer recruiting patients.

3403 studies were found. Here are studies 1 to 50.
1.CompletedA "Pre-Enrollment" Protocol for HIV-Infected Adolescents
Condition: HIV Infections
2.Completed(Ro 24-2027) A Randomized, Double-Blind, Comparative Study of Dideoxycytidine (ddC) versus Zidovudine (AZT) in Patients With AIDS or Advanced ARC
Condition: HIV Infections
3.Suspended10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma
Conditions: adult Hodgkin's lymphoma; adult non-Hodgkin's lymphoma
4.Completed12 week,comparing safety of HMR1964 & insulin aspart used in continuous subcutaneous infusion in type 1 diabetes.
Condition: Diabetes, type I
5.Recruiting12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder
Conditions: chronic myeloproliferative disorders; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; plasma cell neoplasm
6.RecruitingA 14-day study of Racivir when used in combination in HIV-Infected Males
Condition: HIV Infections
7.Recruiting17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma
Conditions: adult solid tumor; Leukemia; Lymphoma; small intestine cancer
8.Recruiting17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas
Conditions: adult solid tumor; Leukemia; Lymphoma
9.Recruiting17-DMAG to Treat Patients with Solid Tumors or Lymphomas
Conditions: Neoplasms; Lymphoma
10.Recruiting17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma
Condition: Cancer
11.Recruiting17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery
Conditions: adult Hodgkin's lymphoma; adult T-cell leukemia and lymphoma; adult non-Hodgkin's lymphoma; adult solid tumor; Cutaneous T-Cell Lymphoma; ...
12.Recruiting17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors
Conditions: Ewing's family of tumors; childhood rhabdomyosarcoma; childhood soft tissue sarcoma; hematopoietic and lymphoid cancer; Neuroblastoma; Osteosarcoma
13.Recruiting17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia
Conditions: unspecified childhood solid tumor, protocol specific; recurrent childhood acute lymphoblastic leukemia; recurrent childhood acute myeloid leukemia; ...
14.Recruiting2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors
Conditions: refractory plasma cell neoplasm; stage III multiple myeloma; unspecified adult solid tumor, protocol specific
15.RecruitingA 24 Week Study of Daily Oral Investigational Drug vs Placebo in Patients with Asthma
Condition: Asthma
16.CompletedA 28-Day Study of Diclazuril in the Treatment of Cryptosporidiosis in Patients with AIDS
Conditions: Cryptosporidiosis; HIV Infections
17.No longer recruiting3 Different Dose Levels of CCI-779 in Subjects with Active Rheumatoid Arthritis on Concomitant Methotrexate Therapy
Condition: Rheumatoid Arthritis
18.No longer recruiting3-AP and Cytarabine in Treating Patients With Hematologic Cancer
Conditions: acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; myelodysplastic and myeloproliferative disease
19.Recruiting3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; Chronic Myelogenous Leukemia; secondary acute myeloid leukemia
20.Recruiting3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome
Conditions: acute leukemia; adult acute monoblastic and acute monocytic leukemia; atypical chronic myeloid leukemia; chronic leukemia; ...
21.Completed3TC (Lamivudine; GR109714X) Open-Label Program
Condition: HIV Infections
22.No longer recruiting4'-Iodo-4'-deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis
Condition: primary systemic amyloidosis
23.Recruiting4-Day-A-Week Treatment Plan for HIV Infected Adolescents
Condition: HIV Infections
24.CompletedA 48-Week (24-Week Baseline Followed by a 24-Week Treatment) Phase II Pilot Study of the Tolerability and Effect/Efficacy of Subcutaneously Administered Insulin-Like Growth Factor-1 (rhIGF) (CEP-151) in Multiple Sclerosis (MS) Patients
Condition: Multiple Sclerosis
25.Recruiting48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection
Condition: HIV Infections
26.Completed506U78 in Treating Patients With Chronic Lymphocytic Leukemia That Has Not Responded to Fludarabine or Alkylating Agents
Conditions: refractory chronic lymphocytic leukemia; T-cell chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia
27.No longer recruiting506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment
Conditions: Leukemia; Lymphoma; Multiple Myeloma
28.No longer recruiting506U78 in Treating Patients With Lymphoma
Conditions: Leukemia; Lymphoma
29.Suspended506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia
Conditions: recurrent adult acute lymphoblastic leukemia; L1 adult acute lymphoblastic leukemia; L2 adult acute lymphoblastic leukemia; ...
30.No longer recruiting506U78 in Treating Patients With Recurrent or Refractory Cutaneous T-cell Lymphoma
Conditions: recurrent cutaneous T-cell lymphoma; recurrent mycosis fungoides/Sezary syndrome
31.No longer recruiting506U78 in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or T-cell Lymphoma
Conditions: recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult T-cell leukemia/lymphoma; angioimmunoblastic T-cell lymphoma; ...
32.No longer recruiting506U78 in Treating Patients With Refractory Hematologic Cancer
Conditions: recurrent childhood lymphoblastic lymphoma; T-cell childhood acute lymphoblastic leukemia; recurrent childhood acute lymphoblastic leukemia
33.No longer recruiting506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: recurrent adult lymphoblastic lymphoma; recurrent adult T-cell leukemia/lymphoma; recurrent childhood lymphoblastic lymphoma; ...
34.Recruiting506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: recurrent adult acute lymphoblastic leukemia; T-cell adult acute lymphoblastic leukemia; recurrent adult lymphoblastic lymphoma
35.Completed6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous Leukemia
Conditions: Previously Treated Myelodysplastic Syndrome; secondary myelodysplastic syndrome; recurrent adult acute myeloid leukemia; ...
36.Completed8-Chloro-cyclic Adenosine Monophosphate in Treating Patients With Recurrent or Refractory Multiple Myeloma
Conditions: stage II multiple myeloma; stage III multiple myeloma; stage I multiple myeloma; refractory plasma cell neoplasm
37.CompletedABT-378/Ritonavir and Efavirenz in HIV-Infected Patients Who Have Taken More Than One Protease Inhibitor in the Past
Condition: HIV Infections
38.RecruitingAcetyl-L-Carnitine for the Treatment of NRTI-Associated Peripheral Neuropathy
Conditions: HIV Infections; Peripheral Nervous System Diseases
39.No longer recruitingAcitretin in Treating Patients With Skin Disease or Skin Cancer
Conditions: actinic keratosis; stage III mycosis fungoides/Sezary syndrome; stage IV mycosis fungoides/Sezary syndrome; skin metastases; ...
40.RecruitingActivation and Function of Eosinophils in Conditions with Blood or Tissue Eosinophilia
Conditions: Asthma; Eosinophilia; Helminthiasis; Hypersensitivity; Parasitic Disease
41.CompletedActive Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and Toxicity
Condition: HIV Infections
42.CompletedActive Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)
Conditions: HIV Infections; Pregnancy
43.CompletedActive Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of VaxSyn Recombinant gp160 (NOTE: Some Patients Receive Placebo)
Conditions: HIV Infections; Pregnancy; HIV Seronegativity
44.TerminatedActive Immunization of HIV-Infected Pregnant Women: A Phase I Study of Safety and Immunogenicity of a rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)
Conditions: HIV Infections; Pregnancy; HIV Seronegativity
45.No longer recruitingActive Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation
Conditions: Graft vs Host Disease; Multiple Myeloma
46.No longer recruitingActive Specific Immunotherapy for Follicular Lymphomas with Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines
Conditions: B Cell Lymphoma; Follicular Lymphoma; Lymphoma
47.RecruitingAcupressure to Treat Nausea and Vomiting in HIV/AIDS Patients
Condition: HIV Infections
48.CompletedAcupuncture and Herbal Treatment of Chronic HIV Sinusitis
Conditions: HIV Infections; Sinusitis
49.RecruitingAcupuncture and Moxa: A RCT for Chronic Diarrhea in HIV Patients
Condition: HIV Infections
50.RecruitingAcupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation
Conditions: Cancer; oral complications of cancer and cancer therapy; Pain

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act